| Oct 27, 2025 |
Oct 28, 2025 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
87.5
|
+31,095
|
1.30%
|
✗
|
$1.4M |
| Jul 2, 2025 |
Jul 3, 2025 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
75.0
|
+21,444
|
0.91%
|
✗
|
$747.6K |
| Jan 3, 2025 |
Jan 6, 2025 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
93.8
|
+61,643
|
2.67%
|
✗
|
$8.3M |
| Sep 20, 2024 |
Sep 20, 2024 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
21.3
|
-216,130
|
-8.57%
|
✓
|
$15.3M |
| Aug 21, 2024 |
Aug 22, 2024 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
53.8
|
-1,000
|
-0.04%
|
✓
|
$69.9K |
| Aug 19, 2024 |
Aug 19, 2024 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
31.3
|
-112,870
|
-4.57%
|
✓
|
$7.4M |
| Jul 29, 2024 |
Jul 31, 2024 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
93.8
|
+88,474
|
3.90%
|
✗
|
$6.7M |
| Mar 27, 2024 |
Mar 27, 2024 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
95.0
|
+67,719
|
3.08%
|
✗
|
$12.8M |
| Mar 1, 2024 |
Mar 4, 2024 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
95.0
|
+58,852
|
2.75%
|
✗
|
$13.9M |
| Feb 9, 2024 |
Feb 9, 2024 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
36.3
|
-45,000
|
-2.06%
|
✓
|
$1.3M |
| Feb 8, 2024 |
Feb 8, 2024 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
35.0
|
-269,079
|
-2.33%
|
✓
|
$7.2M |
| Jan 31, 2024 |
Jan 31, 2024 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
32.5
|
-85,000
|
-3.62%
|
✓
|
$2.1M |
| Jan 30, 2024 |
Jan 30, 2024 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-35,000
|
-1.52%
|
✓
|
$838.3K |
| Jan 3, 2024 |
Jan 4, 2024 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
92.5
|
+55,808
|
2.53%
|
✗
|
$4.5M |
| May 1, 2023 |
May 1, 2023 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
36.3
|
-45,000
|
-2.01%
|
✓
|
$1M |
| Apr 19, 2023 |
Apr 21, 2023 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-35,000
|
-1.54%
|
✓
|
$750.8K |
| Apr 17, 2023 |
Apr 18, 2023 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
27.5
|
-155,000
|
-6.37%
|
✓
|
$3.2M |
| Apr 13, 2023 |
Apr 13, 2023 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
32.5
|
-79,336
|
-3.32%
|
✓
|
$1.5M |
| Mar 30, 2023 |
Apr 3, 2023 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
38.8
|
-143,352
|
-1.02%
|
✓
|
$7.7M |
| Dec 30, 2022 |
Jan 4, 2023 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
100.0
|
+225,336
|
11.00%
|
✗
|
$1.4M |
| Jan 3, 2022 |
Jan 5, 2022 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
92.5
|
+110,582
|
5.74%
|
✗
|
$299.4K |
| Sep 28, 2021 |
Sep 30, 2021 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
82.5
|
+27,750
|
1.46%
|
✗
|
$180.4K |
| Jan 19, 2021 |
Jan 19, 2021 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
51.3
|
-5,611
|
-0.30%
|
✗
|
$37.5K |
| Jan 3, 2021 |
Jan 6, 2021 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
92.5
|
+155,815
|
8.93%
|
✗
|
$276K |
| Sep 15, 2020 |
Sep 16, 2020 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
82.5
|
+36,308
|
2.13%
|
✗
|
$120K |
| Jan 19, 2020 |
Jan 21, 2020 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
51.3
|
-3,195
|
-0.19%
|
✗
|
$22.9K |
| Jan 3, 2020 |
Jan 3, 2020 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
90.0
|
+146,551
|
9.39%
|
✗
|
$52.7K |
| Jan 19, 2019 |
Jan 22, 2019 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
51.3
|
-4,333
|
-0.28%
|
✗
|
$38K |
| May 4, 2018 |
May 8, 2018 |
Viking Therapeutics, Inc.
|
CEO |
Sell |
48.8
|
-10,086
|
-0.68%
|
✗
|
$42.6K |
| May 4, 2015 |
May 6, 2015 |
Viking Therapeutics, Inc.
|
CEO |
Buy |
42.5
|
-2,209,560
|
-34.40%
|
✗
|
$155.1K |